Zobrazeno 1 - 10
of 66
pro vyhledávání: ''
Autor:
Alessandro Vicentini, Haran Burri, Andrea Demarchi, Maria Luce Caputo, Pedro Brugada, Antonio Scalone, Carlo de Asmundis, Ilaria Passarelli, Mehdi Namdar, Fabio Cattaneo, Paola Berne, Dipen Shah, Tardu Özkartal, Gavino Casu, Angelo Auricchio, Giulio Conte, Francesca Salghetti, Stefano Mameli, Gaetano M. De Ferrari, Catherine Klersy
Publikováno v:
EP Europace. 24:845-854
Aims Ajmaline challenge can unmask subcutaneous implantable cardioverter-defibrillator (S-ICD) screening failure in patients with Brugada syndrome (BrS) and non-diagnostic baseline electrocardiogram (ECG). The efficacy of the SMART Pass (SP) filter,
Autor:
Michele Malagù, Francesco Vitali, Alessandro Brieda, Claudio Rapezzi, Cristina Musolino, Cristina Balla, Martina De Raffele, Rosario Cultrera, Matteo Bertini, Paolo Cimaglia, Matteo Serenelli, Enea Tazzari
Publikováno v:
EP Europace. 24:413-420
Aims In patients undergoing cardiac implantable electronic device (CIED) intervention, routine pre-procedure antibiotic prophylaxis is recommended. A more powerful antibiotic protocol has been suggested in patients at high risk of infection. Stratifi
Publikováno v:
EP Europace. 24:181-192
Implantable cardioverter-defibrillators (ICDs) have revolutionized the treatment of acquired or inherited cardiac diseases associated with a high risk of sudden cardiac death due to ventricular tachyarrhythmias. Contemporary ICD devices offer reliabl
Autor:
Alex Hørby Christensen, Pyotr G. Platonov, Anneli Svensson, Jesper Hastrup Svendsen, Pia Dahlberg, Kristina H. Haugaa, Henrik Jensen, Henning Bundgaard, Tanja Charlotte Frederiksen, Trine Madsen, Christine Rootwelt-Norberg, Tiina Heliö
Publikováno v:
Christensen, A H, Platonov, P G, Svensson, A, Jensen, H K, Rootwelt-Norberg, C, Dahlberg, P, Madsen, T, Frederiksen, T C, Heliö, T, Haugaa, K H, Bundgaard, H & Svendsen, J H 2022, ' Complications of implantable cardioverter-defibrillator treatment in arrhythmogenic right ventricular cardiomyopathy ', Europace, vol. 24, no. 2, pp. 306–312 . https://doi.org/10.1093/europace/euab112
Christensen, A H, Platonov, P G, Svensson, A, Jensen, H K, Rootwelt-Norberg, C, Dahlberg, P, Madsen, T, Frederiksen, T C, Heliö, T, Haugaa, K H, Bundgaard, H & Svendsen, J H 2022, ' Complications of implantable cardioverter-defibrillator treatment in arrhythmogenic right ventricular cardiomyopathy ', Europace, vol. 24, no. 2, pp. 306-312 . https://doi.org/10.1093/europace/euab112
Christensen, A H, Platonov, P G, Svensson, A, Jensen, H K, Rootwelt-Norberg, C, Dahlberg, P, Madsen, T, Frederiksen, T C, Heliö, T, Haugaa, K H, Bundgaard, H & Svendsen, J H 2022, ' Complications of implantable cardioverter-defibrillator treatment in arrhythmogenic right ventricular cardiomyopathy ', Europace, vol. 24, no. 2, pp. 306-312 . https://doi.org/10.1093/europace/euab112
Aims Treatment with implantable cardioverter-defibrillators (ICD) is a cornerstone for prevention of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy (ARVC). We aimed at describing the complications associated with ICD treatmen
Autor:
Charles J. Love, Arnold J. Greenspon, François Philippon, Christopher Cooper, Heather L. Bloom, Fozia Z Ahmed, Khaldoun G. Tarakji, Jens Brock Johansen, Carina Blomström-Lundqvist, Daniel R. Lexcen, Andrew D. Krahn, Ying Xia, Christopher Ellis, Andreas Goette, Lou Sherfesee, Reece Holbrook, Swathi Seshadri
Publikováno v:
Ahmed, F Z, Blomström-Lundqvist, C, Bloom, H, Cooper, C, Ellis, C, Goette, A, Greenspon, A J, Love, C J, Johansen, J B, Philippon, F, Tarakji, K G, Holbrook, R, Sherfesee, L, Xia, Y, Seshadri, S, Lexcen, D R & Krahn, A D 2021, ' Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score ', Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, vol. 23, no. 9, pp. 1446-1455 . https://doi.org/10.1093/europace/euab028
Europace
Europace
Aim The Prevention of Arrhythmia Device Infection Trial (PADIT) infection risk score, developed based on a large prospectively collected data set, identified five independent predictors of cardiac implantable electronic device (CIED) infection. We pe
Autor:
François Philippon, Sharath Kumar, Andrew D. Krahn, Derek V. Exner, Pablo B. Nery, Vidal Essebag, Laurence D. Sterns, Benoit Coutu, Jason Davis, Bernard Thibault, Ratika Parkash, Roopinder K. Sandhu, George A. Wells, Matthew T. Bennett, Iqwal Mangat, Raymond Yee
Publikováno v:
EP Europace. 23:1319-1323
Aims Cardiac implantable electronic devices with device advisories have the potential of device malfunction. Remote monitoring (RM) of devices has been suggested to allow the identification of abnormal device performance and permit early intervention
Autor:
Jacob Joseph, Hirad Yarmohammadi, Jagmeet P. Singh, Peter Hoffmeister, Sebhat A. Erqou, David Martin, Adelqui Peralta, Matthew F Yuyun, Justin B. Echouffo Tcheugui
Publikováno v:
EP Europace. 23:1262-1274
Aims Response to cardiac resynchronization therapy (CRT) is associated with improved survival, and reduction in heart failure hospitalization, and ventricular arrhythmia (VA) risk. However, the impact of CRT super-response [CRT-SR, increase in left v
Autor:
Norah Yap, Georgia Spentzou, Sujeev Mathur, Tara Bharucha, Elspeth Brown, Dominic Hares, Gabrielle Norrish, Maria Ilina, Caroline Jones, Amos Wong, Shankar Sadagopan, Piers E.F. Daubeney, Jane Matthews, Arthur M. Yue, Zdenka Reinhardt, Jan Till, Krishnakumar Pillai, Alan Graham Stuart, Michael Bowes, Jasveer Mangat, Karen McLeod, Vinay Bhole, Katie Linter, Ella Field, Henry Chubb, Eric Rosenthal, Satish Adwani, Juan Pablo Kaski, Orhan Uzun
Publikováno v:
Europace
Aims Sudden cardiac death (SCD) is the most common mode of death in paediatric hypertrophic cardiomyopathy (HCM). This study describes the implant and programming strategies with clinical outcomes following implantable cardioverter-defibrillator (ICD
Autor:
Yong Mei Cha, Gurukripa N. Kowlgi
Publikováno v:
EP Europace. 22:1768-1780
Ventricular electrical storm (VES) is a clinical scenario characterized by the clustering of multiple episodes of sustained ventricular arrhythmias (VA) over a short duration. Patients with VES are prone to psychological disorders, heart failure deco
Publikováno v:
EP Europace. 22:1520-1525
Aims Right ventricular (RV) lead placement can be contraindicated in patients after tricuspid valve (TV) surgery. Placement of the implantable cardiac-defibrillator (ICD) lead in the middle cardiac vein (MCV) can be a viable option in these patients